Export

Nilotinib
Essential medicine status
General description
Nilotinib is a BCR-ABL tyrosine kinase inhibitor used in treatment protocols for chronic myeloid leukaemia
INN
Nilotinib
Medicine type
Chemical agent
EML status history
Wikipedia
DrugBank
Recommendations
Section
Targeted therapies
  • Oral > Solid: 150 mg capsule; 200 mg capsule